DASHENLIN PHARMACEUTICAL GROUP CO., LTD.

News DaShenLin Pharmaceutical Group Co., Ltd.

Equities

603233

CNE100002RG2

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-17 pm EDT			5-day change	1st Jan Change
22.3 ^CNY	+2.39%		+4.11%	-10.44%

Mar. 18	Dashenlin Pharmaceutical to Buy Back Up to 200 Million Yuan Shares	MT
Mar. 05	Dashenlin Pharmaceutical Plans to Buy Back Up to 200 Million Yuan Worth of Shares	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Dashenlin Pharmaceutical to Buy Back Up to 200 Million Yuan Shares	Mar. 18	MT
Dashenlin Pharmaceutical Plans to Buy Back Up to 200 Million Yuan Worth of Shares	Mar. 04	MT
DaShenLin Pharmaceutical Group Co., Ltd. cancelled the transaction announced on January 19, 2023	Jan. 22	CI
Dashenlin Pharmaceutical to Boost Stake in Local Pharmacy Chain to 66% For 30 Million Yuan	Nov. 27	MT
DaShenLin Pharmaceutical Group Co., Ltd. agreed to acquire 15% stake in Chongqing Wanjiayan Pharmacy Chain Co., Ltd from Chongqing Wanjiayan Health Industry Group Co., Ltd. and Bai Run for CNY 30 million.	Nov. 24	CI
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-29	CI
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-27	CI
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Dashenlin Pharmaceutical Unit Acquires Land for 1.20 Billion Yuan; Shares Jump 4%	23-03-28	MT
DaShenLin Pharmaceutical Group Co., Ltd. announced that it expects to receive CNY 3.025 billion in funding	23-01-18	CI
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
Beijing Mulls Banning Internet Healthcare Firms From Selling Drugs Online	22-06-22	MT
UBS Adjusts Dashenlin Pharmaceutical's Price Target to 40 Yuan From 73.5 Yuan, Keeps at Buy	22-05-06	MT
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-27	CI
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-27	CI
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-27	CI
Dashenlin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-29	CI
Dashenlin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-28	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News DaShenLin Pharmaceutical Group Co., Ltd.

Equities

603233

CNE100002RG2

Summary

Filters